Wikipedia -WSS

Wikipedia

author：entertainment 2025-08-12 11:28:39 - browse：7511

This image provided by Eisai in January 2023 shows vials and packaging for their medication, Leqembi. — Illustration: Alex Hogan/STAT; Photo: Eisai via AP

Seven months after US drug regulators fully approved Biogen’s treatment for Alzheimer’s disease, only about 2,000 patients are taking the medicine nationwide, the company said Tuesday.

Biogen’s chief executive, Christopher A. Viehbacher, said as the firm released fourth-quarter earnings that he had expected the slow uptake and sees considerable demand for the medication. He told reporters that 3,800 patients with early-stage Alzheimer’s have signed up on multiple registries to receive the drug, called Leqembi, as of last month.

Before patients can get the drug, which costs $26,500-a-year, they must undergo a brain scan or a spinal tap to confirm that they have build-up of deposits of a sticky toxic protein called beta-amyloid that is a hallmark of the disease.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Beware reading your test results before your doctor does

focus

explore

WSS

The biotech scorecard for Q3: 15 stock

How to increase colonoscopy rates? Looks like an AI can help

Ultragenyx gene therapy for rare liver ailment succeeds in late

Ultragenyx gene therapy for rare liver ailment succeeds in late

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

AstraZeneca lung cancer study comes in below expectations

Wikipedia

Wikipedia

entertainment

In age of alternative facts, a scholarly course on calling out crap

Shifting the focus from loneliness to social health

Malaria cases in Florida and Texas: Here’s what you need to know

UpToDate has a racism problem: Dr. Stanley Goldfarb

Anesthesiologist group: stop taking Ozempic before surgery

Use doctors trained outside the U.S. to ease the physician shortage

23andMe had bad news about my health. I wish a person had delivered it

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

The cancer drug shortage isn’t new — and neither are the solutions

Change Healthcare can notify patients about the breach, HHS says

entertainment

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

Letters to First Opinion on caregivers, digital health, and more

Fatty liver disease was alleviated by Lilly’s ‘triple

Skip the lead apron during X

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

focus

focus

explore

focus